SCHEMBL4419679

SCHEMBL4419679

CC(C(=O)NN)N1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.54
AAK1 Q2M2I8 1/20 0.49
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
PKM P14618 1/20 0.42
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 2/20 0.40
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18687290 0.82 AAK1 (0.47) POLBAAK1MAPK1SMN1; SMN2PKM
SCHEMBL28800785 0.82 AAK1 (0.47) POLBAAK1MAPK1SMN1; SMN2PKM
SCHEMBL4088981 0.82 ATM (0.49) POLBSMN1; SMN2ALDH1A1KDM4EKMT2A
SCHEMBL9471506 0.78 KDM4E (0.51) POLBSMN1; SMN2ALDH1A1KDM4ETSHR
SCHEMBL29902875 0.78 HTT (0.53) POLBAAK1MAPK1SMN1; SMN2PKM
SCHEMBL2129974 0.78 AAK1 (0.42) POLBAAK1MAPK1SMN1; SMN2PKM
SCHEMBL2715770 0.78 AAK1 (0.42) POLBAAK1MAPK1SMN1; SMN2PKM
Water SCHEMBL29902298 0.76 AAK1 (0.41) POLBAAK1MAPK1SMN1; SMN2PKM
Water SCHEMBL29947214 0.76 AAK1 (0.41) POLBAAK1MAPK1SMN1; SMN2PKM
SCHEMBL3714585 0.75 ALDH1A1 (0.50) AAK1MAPK1SMN1; SMN2PKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663291-B1 NUCLEAR TRANSPORT MODULATORS AND USES THEREOF KARYOPHARM THERAPEUTICS INC (US) 2024-12-18 EP disclosed
EP-2858991-A2 NUCLEAR TRANSPORT MODULATORS AND USES THEREOF Karyopharm Therapeutics, Inc. (US) 2015-04-15 EP disclosed
WO-2013170068-A2 NUCLEAR TRANSPORT MODULATORS AND USES THEREOF KARYOPHARM THERAPEUTICS, INC. (US) 2013-11-14 WO disclosed
CN-100587001-C Polyacetal resin composition POLYPLASTICS CO 2010-02-03 CN disclosed
US-7638565-B2 Polyacetal resin composition POLYPLASTICS CO., LTD. (JP) 2009-12-29 US disclosed
US-20070054998-A1 Polyacetal resin composition POLYPLASTICS CO., LTD. (JP) 2007-03-08 US disclosed
CN-1878834-A Polyacetal resin composition POLYPLASTICS CO (JP) 2006-12-13 CN disclosed
EP-1686156-A1 POLYACETAL RESIN COMPOSITION Polyplastics Co., Ltd. (JP) 2006-08-02 EP disclosed
EP-1296961-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-02 EP disclosed
WO-2001090083-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 WO disclosed
US-4593027-A 3-aryl-7-chloro-3,4-dihydroacridine-1,9(2H,10H)-dione 1-oximes and 1-hydrazone derivatives, their salts, a process for their preparation, agents containing them and their use HOECHST AKTIENGESELLSCHAFT (DE) 1986-06-03 US disclosed